TRAV22

mutation — cross-omics
Cross-omicsMUTATION → IMMUNEPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, TRAV22 mutation is significantly associated with the immune_cell of many other genes, with 5 significant associations in total. SKCM shows the largest number of these associations.

The most reproducible TRAV22-associated genes across cancer lineages are Eosinophils, iDC, and Monocytes. Each is linked with TRAV22 in more than 1 cancer types. Because this analysis shows association rather than direction, both TRAV22-to-partner and partner-to-TRAV22 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (TRAV22→partner) and Y-score (partner→TRAV22) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
SKCMEosinophils →+0.077+2.538<.001.00531
SKCMiDC →+0.192+2.465.012.01131
LUADMonocytes →+0.026+3.683.035.04931
SKCMMacrophages →-0.034-3.540.019.00311
SKCMMacrophages M1 →-0.028-3.527.021.00311
Each partner links to its Q-omics profile. Showing the 5 strongest of 5 associations by consensus.

Exploration